SLN Competitors & Alternatives
Compare Silence Therapeutics PLC with similar stocks in the same industry
Biotechnology
SLN
Main Stock$19.80
Tradestie Score
42
Market Cap
$240.89M
Revenue Growth
2.0%
Analyst Upside
-0.3%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.47
|
$1.29B | - | 38 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.55
|
$1.29B | - | 54 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.13
|
$1.29B | - | 67 | Compare |
|
ZYME
Zymeworks Inc.
|
$27.16
|
$1.28B | 59.4 | 48 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.08
|
$1.27B | - | 54 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.67
|
$1.18B | 45.2 | 65 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$49.56
|
$1.17B | - | 33 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$18.98
|
$1.15B | 8.1 | 50 | Compare |
More SLN Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry